Schnieders Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$300K Hold
776
0.04% 197
2026
Q1
$227K Sell
776
-15
-2% -$4.93K 0.04% 194
2025
Q4
$277K Hold
791
0.04% 180
2025
Q3
$256K Sell
791
-39
-5% -$12.1K 0.05% 198
2025
Q2
$323K Sell
830
-8
-1% -$3.22K 0.06% 174
2025
Q1
$364K Sell
838
-10
-1% -$4.01K 0.08% 147
2024
Q4
$313K Hold
848
0.06% 162
2024
Q3
$441K Buy
848
+83
+11% +$44.3K 0.08% 140
2024
Q2
$415K Hold
765
0.08% 131
2024
Q1
$397K Hold
765
0.08% 137
2023
Q4
$361K Sell
765
-20
-3% -$9.25K 0.08% 146
2023
Q3
$342K Hold
785
0.08% 139
2023
Q2
$349K Hold
785
0.07% 146
2023
Q1
$361K Hold
785
0.08% 147
2022
Q4
$403K Buy
785
+25
+3% +$12.7K 0.09% 136
2022
Q3
$345K Hold
760
0.09% 141
2022
Q2
$367K Sell
760
-5
-0.7% -$2.47K 0.11% 134
2022
Q1
$376K Buy
765
+59
+8% +$27K 0.09% 147
2021
Q4
$327K Buy
706
+95
+16% +$40K 0.08% 153
2021
Q3
$228K Buy
+611
New +$232K 0.06% 175
2020
Q1
Sell
-859
Closed -$259K 155
2019
Q4
$259K Hold
859
0.09% 150
2019
Q3
$206K Sell
859
-50
-6% -$13.7K 0.08% 156
2019
Q2
$257K Sell
909
-100
-10% -$27.3K 0.1% 137
2019
Q1
$289K Hold
1,009
0.12% 120
2018
Q4
$264K Sell
1,009
-5
-0.5% -$1.38K 0.13% 111
2018
Q3
$278K Buy
1,014
+69
+7% +$17.9K 0.11% 120
2018
Q2
$225K Hold
945
0.1% 140
2018
Q1
$208K Hold
945
0.09% 142
2017
Q4
$213K Buy
+945
New +$201K 0.09% 147

Other funds holding ELV

Schnieders Capital Management's ELV Position: Q2 2026 in Review

Schnieders Capital Management held its Elevance Health (ELV) position steady in Q2 2026 at 776 shares worth $300K. The position accounts for 0.04% of the portfolio, ranked #197.

Schnieders Capital Management first reported a position in ELV in Q4 2017 and has held it in 29 quarters since. The position peaked at $441K in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Schnieders Capital Management held 776 shares of Elevance Health worth $300K as of Q2 2026.
  • Schnieders Capital Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.04% of Schnieders Capital Management's portfolio in Q2 2026, its #197 holding.
  • Schnieders Capital Management first reported a position in Elevance Health in Q4 2017 and has held it in 29 quarters since.
  • Schnieders Capital Management's Elevance Health position peaked at $441K in Q3 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Schnieders Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.